IS6709A - Fljótandi samsetningar metformíns - Google Patents

Fljótandi samsetningar metformíns

Info

Publication number
IS6709A
IS6709A IS6709A IS6709A IS6709A IS 6709 A IS6709 A IS 6709A IS 6709 A IS6709 A IS 6709A IS 6709 A IS6709 A IS 6709A IS 6709 A IS6709 A IS 6709A
Authority
IS
Iceland
Prior art keywords
metformin
liquid formulations
formulations
liquid
Prior art date
Application number
IS6709A
Other languages
English (en)
Inventor
Chandran Ravi
Gogia Ashish
Original Assignee
Ranbaxy Signature Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22836292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6709(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Signature Llc filed Critical Ranbaxy Signature Llc
Publication of IS6709A publication Critical patent/IS6709A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS6709A 2000-08-07 2003-02-06 Fljótandi samsetningar metformíns IS6709A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22339100P 2000-08-07 2000-08-07
PCT/IB2001/001409 WO2002011716A2 (en) 2000-08-07 2001-08-07 Liquid formulation of metformin

Publications (1)

Publication Number Publication Date
IS6709A true IS6709A (is) 2003-02-06

Family

ID=22836292

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6709A IS6709A (is) 2000-08-07 2003-02-06 Fljótandi samsetningar metformíns

Country Status (19)

Country Link
US (2) US6559187B2 (is)
EP (1) EP1387675A2 (is)
JP (1) JP2004505913A (is)
CN (1) CN1635881A (is)
AU (1) AU2001276598A1 (is)
BR (1) BR0113102A (is)
CA (1) CA2416767A1 (is)
HR (1) HRP20030161A2 (is)
HU (1) HUP0302700A3 (is)
IL (1) IL154307A0 (is)
IS (1) IS6709A (is)
MX (1) MXPA03001157A (is)
NZ (1) NZ524519A (is)
PL (1) PL365135A1 (is)
RU (1) RU2003104808A (is)
SK (1) SK2102003A3 (is)
WO (1) WO2002011716A2 (is)
YU (1) YU8803A (is)
ZA (1) ZA200300990B (is)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
BR0113102A (pt) 2000-08-07 2003-07-08 Ranbaxy Signature Llc Formulação lìquida de metformina
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
WO2003061643A1 (es) * 2002-01-25 2003-07-31 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
EP2070551B1 (en) * 2003-01-31 2013-01-16 Simply Thick LLC Process for producing thickened beverages for dysphagia
WO2004082664A1 (en) * 2003-03-21 2004-09-30 Ranbaxy Laboratories Limited Water-soluble tablets of metformin
US20050054731A1 (en) * 2003-09-08 2005-03-10 Franco Folli Multi-system therapy for diabetes, the metabolic syndrome and obesity
CA2542755A1 (en) * 2003-10-17 2005-04-28 Medrx Co., Ltd. Biguanide drug-containing jelly preparation
JP4814636B2 (ja) * 2004-01-29 2011-11-16 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
US20100048454A1 (en) * 2004-08-03 2010-02-25 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
PT1878426E (pt) * 2005-04-26 2010-06-28 Dainippon Sumitomo Pharma Co Preparação granulada contendo um composto de biguanida
US20070015839A1 (en) * 2005-07-14 2007-01-18 Franco Folli Daily Dosage Regimen for Treating Diabetes, Obesity, Metabolic Syndrome and Polycystic Ovary Syndrome
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
US8591938B2 (en) * 2006-07-21 2013-11-26 Lyne Laboratories, Inc. Liquid compositions of calcium acetate
EP2051696A2 (en) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
TWI440456B (zh) * 2007-01-16 2014-06-11 用於治療代謝性症候群之新穎化合物
CA2685936C (en) * 2007-05-07 2016-07-12 Clearly Superior, Inc. Food thickening agent, method for producing food thickening agent
BRPI0815095B1 (pt) * 2007-07-17 2021-04-13 Metabolon, Inc Método de classificação de um indivíduo de acordo com a tolerância à glicose predita em tolerância à glicose normal (ngt), tolerância à glicose de jejum prejudicada (ifg), ou tolerância à glicose prejudicada (igt), para diabetes tipo 2, método de determinação da suscetibilidade de um indivíduo a diabetes tipo 2 e método de monitoramento da progressão ou regressão do pré- diabetes em um indivíduo
US8337824B2 (en) * 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
CN101658487B (zh) * 2008-08-28 2011-10-05 北京天川军威医药技术开发有限公司 格列美脲水溶液给药系统及其制备方法
AU2010225923B2 (en) * 2009-03-16 2016-10-27 Ipintl, Llc Treating Alzheimer's disease and osteoporosis and reducing aging
MX2012005998A (es) * 2010-04-13 2013-06-18 Nucitec Sa De Cv Composiciones y metodos para el tratamiento de la diabetes mellitus tipo 2 y desordenes relacionados.
WO2011154975A2 (en) 2010-06-08 2011-12-15 Cadila Healthcare Limited Pharmaceutical compositions of metformin
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
EP2801349A1 (en) * 2013-05-06 2014-11-12 Siegfried AG Oral Pharmaceutical Formulation
WO2016016845A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
CA2947528C (en) 2014-05-01 2023-09-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
RU2731098C2 (ru) * 2014-08-19 2020-08-28 Нэшнл Юниверсити Корпорейшн Окаяма Юниверсити Способ улучшения функции иммунных клеток и оценки мультифункциональности иммунных клеток
EP3288539A4 (en) * 2015-05-01 2019-07-10 Sun Pharmaceutical Industries Ltd EXTENDED RELEASE LIQUID METFORMIN COMPOSITIONS
AU2016310470A1 (en) 2015-08-21 2018-02-22 Aprecia Pharmaceuticals LLC Three-dimensional printing system and equipment assembly
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
BR112019006401A2 (pt) * 2016-09-30 2019-06-25 Laboratorios Silanes S A De C V glicinato de metformina, composições farmacêuticas que compreendem o mesmo e métodos de uso do mesmo
EP3479845A1 (en) * 2017-11-06 2019-05-08 Stalicla S.A. Challenge test for diagnosing subtype of autism spectrum disease
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632623A (is) 1962-06-14
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2951135A1 (de) 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4584189A (en) * 1984-09-28 1986-04-22 Hercules Incorporated Bactericidal toothpastes
DE3543999A1 (de) 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
US5614492A (en) 1986-05-05 1997-03-25 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
ATE87476T1 (de) * 1988-11-10 1993-04-15 Ciba Geigy Ag Fluessige orale formulierung.
US5594016A (en) 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
WO1999029314A1 (en) 1997-12-08 1999-06-17 Bristol-Myers Squibb Company Novel salts of metformin and method
DK1082109T3 (da) * 1998-04-29 2004-08-09 Sumitomo Pharma Oral formulering omfattende biguanid og en organisk syre
BR0113102A (pt) 2000-08-07 2003-07-08 Ranbaxy Signature Llc Formulação lìquida de metformina

Also Published As

Publication number Publication date
SK2102003A3 (en) 2003-08-05
ZA200300990B (en) 2003-10-31
JP2004505913A (ja) 2004-02-26
NZ524519A (en) 2004-09-24
EP1387675A2 (en) 2004-02-11
YU8803A (sh) 2006-01-16
PL365135A1 (en) 2004-12-27
WO2002011716A2 (en) 2002-02-14
HUP0302700A3 (en) 2005-05-30
IL154307A0 (en) 2003-09-17
US20020040063A1 (en) 2002-04-04
HRP20030161A2 (en) 2004-08-31
BR0113102A (pt) 2003-07-08
US6559187B2 (en) 2003-05-06
HUP0302700A2 (hu) 2003-12-29
CN1635881A (zh) 2005-07-06
US20030149111A1 (en) 2003-08-07
US6890957B2 (en) 2005-05-10
MXPA03001157A (es) 2004-02-17
CA2416767A1 (en) 2002-02-14
AU2001276598A1 (en) 2002-02-18
RU2003104808A (ru) 2004-08-20
WO2002011716A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
IS6709A (is) Fljótandi samsetningar metformíns
ID30590A (id) Celana sekali pakai jenis-celana pendek
EE05421B1 (et) Fulvestrandi formulatsioonid
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
CY2004011I1 (el) Aσυμμετρη συνθεση της πρεγαβαλινης
DK1317177T3 (da) Desinficerende formuleringer
ATE263487T1 (de) Flüssige formulierungen
ID30187A (id) Dongkrak jenis pantagraf
EE05020B1 (et) Glburiidi ravimkoostis
DK1277471T3 (da) Stabilt væskepræparat omfattende sitafloxacin
ATE268116T1 (de) Mesotrion-formulierungen
NO20031953D0 (no) Anvendelse av disazoforbindelser
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60106687D1 (de) Tupfer
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
SE0002190D0 (sv) Use of a composition
SE0004003D0 (sv) Synthesis of FLG
ITMI20000110V0 (it) Struttura di riloga
SE0003868D0 (sv) Use of bixin
SE0002629D0 (sv) Novel compounds and their use
FI20000526A0 (fi) Preassurans-sammutusjärjestelmä
SE0103831D0 (sv) Use of a composition
FIU20000034U0 (fi) Kanteleen sävelvaihtomekanismi
FR2810531B1 (fr) Trocart de coelio-chirurgie
UA4058S (uk) Комплект етикеток